{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 458798059
| IUPAC_name = 3-1-Benzhydryl-3-azetidinyl 5-isopropyl 2-amino-6-methyl-4-(''m''-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
| image = Azelnidipine structure.svg

<!--Clinical data-->
| tradename = CalBlock
| Drugs.com = {{drugs.com|international|azelnidipine}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = Rx-only
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 123524-52-7
| ATC_prefix = none
| ATC_suffix =  
| ATC_supplemental =  
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1275868
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C33H34N4O6/c1-20(2)42-32(38)27-21(3)35-31(34)29(28(27)24-15-10-16-25(17-24)37(40)41)33(39)43-26-18-36(19-26)30(22-11-6-4-7-12-22)23-13-8-5-9-14-23/h4-17,20,26,28,30,35H,18-19,34H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ZKFQEACEUNWPMT-UHFFFAOYSA-N
| PubChem = 65948
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 59352
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = PV23P19YUG
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01145

<!--Chemical data-->
| chemical_formula =  
| C=33 | H=34 | N=4 | O=6 
| molecular_weight = 582.64 g/mol
| smiles = [O-][N+](=O)c1cccc(c1)C5C(/C(=O)OC(C)C)=C(\NC(\N)=C5\C(=O)OC4CN(C(c2ccccc2)c3ccccc3)C4)C
}}

'''Azelnidipine''' ([[International Nonproprietary Name|INN]]; marketed under the brand name '''CalBlock — カルブロック''') is a [[dihydropyridine]] [[calcium channel blocker]]. 
It is sold in [[Japan]] by [[Daiichi-Sankyo]] pharmaceuticals, Inc.
Unlike [[nicardipine]], it has a gradual onset and has a long-lasting hypotensive effect, with little increase in heart rate.<ref name="pmid2810942">{{cite journal |vauthors=Oizumi K, Nishino H, Koike H, Sada T, Miyamoto M, Kimura T |title=Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker |journal=Jpn. J. Pharmacol. |volume=51 |issue=1 |pages=57–64 |date=September 1989 |pmid=2810942 |doi= 10.1254/jjp.51.57|url=http://joi.jlc.jst.go.jp/JST.Journalarchive/jphs1951/51.57?from=PubMed}}<sup>[http://scholar.google.co.uk/scholar?hl=en&lr=&q=intitle%3AAntihypertensive+effects+of+CS-905%2C+a+novel+dihydropyridine+Ca%2B%2B+channel+blocker&as_publication=Jpn.+J.+Pharmacol.&as_ylo=1989&as_yhi=1989&btnG=Search Scholar search]</sup> {{dead link|date=April 2009}}</ref>

==References==
{{Reflist}}

{{Calcium channel blockers}}

[[Category:Aldosterone synthase inhibitors]]
[[Category:Calcium channel blockers]]
[[Category:Dihydropyridines]]
[[Category:Carboxylate esters]]
[[Category:Azetidines]]
[[Category:Nitrobenzenes]]


{{Cardiovascular-drug-stub}}